223 related articles for article (PubMed ID: 29346247)
21. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
[TBL] [Abstract][Full Text] [Related]
22. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
[TBL] [Abstract][Full Text] [Related]
23. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
Gilbert CR; Gorden JA
Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage.
Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
Radiology; 2008 Mar; 246(3):956-63. PubMed ID: 18309017
[TBL] [Abstract][Full Text] [Related]
25. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
Kanellakis NI; Wrightson JM; Hallifax R; Bedawi EO; Mercer R; Hassan M; Asciak R; Hedley E; Dobson M; Dong T; Psallidas I; Rahman NM
BMJ Open Respir Res; 2019; 6(1):e000440. PubMed ID: 31673364
[TBL] [Abstract][Full Text] [Related]
26. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults.
Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D
Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340
[TBL] [Abstract][Full Text] [Related]
27. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
Piccolo F; Popowicz N; Wong D; Lee YC
J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
[TBL] [Abstract][Full Text] [Related]
29. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
30. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
Biswas A; Jantz MA; Barnes MD; Mehta HJ
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
[No Abstract] [Full Text] [Related]
31. Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.
Townsend A; Raju H; Serpa KA; Pruett R; Razi SS; Tarrazzi FA; Tami CM; Block MI
BMC Pulm Med; 2022 Dec; 22(1):464. PubMed ID: 36471325
[TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.
Lansley SM; Cheah HM; Varano Della Vergiliana JF; Chakera A; Lee YC
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):105-12. PubMed ID: 25474480
[TBL] [Abstract][Full Text] [Related]
33. Intrapleural alteplase in a patient with complicated pleural effusion.
Walker CA; Shirk MB; Tschampel MM; Visconti JA
Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
[TBL] [Abstract][Full Text] [Related]
34. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
Levinson GM; Pennington DW
Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
[TBL] [Abstract][Full Text] [Related]
35. Management of parapneumonic effusions and empyema.
Psallidas I; Corcoran JP; Rahman NM
Semin Respir Crit Care Med; 2014 Dec; 35(6):715-22. PubMed ID: 25463162
[TBL] [Abstract][Full Text] [Related]
36. Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection.
Popowicz N; Piccolo F; Shrestha R; Lee YC
Respirol Case Rep; 2014 Jun; 2(2):87-9. PubMed ID: 25473577
[TBL] [Abstract][Full Text] [Related]
37. Intrapleural heparin or heparin combined with human recombinant DNase is not effective in the treatment of empyema in a rabbit model.
Dikensoy O; Zhu Z; Na MJ; Liao H; Donnelly E; Light RW
Respirology; 2006 Nov; 11(6):755-60. PubMed ID: 17052304
[TBL] [Abstract][Full Text] [Related]
38. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
[TBL] [Abstract][Full Text] [Related]
39. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
